VOLITIONRX LTD

Profile

Company Names

VOLITIONRX LTD

Addresses

1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV 89014

1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV 89014

1 SCOTTS RD, #24-05 SHAW CENTRE, SINGAPORE, U0 228208

1 SCOTTS ROAD, #24-05 SHAW CENTRE, SINGAPORE, U0 228208

150 ORCHARD ROAD, ORCHARD PLAZA 08-02, U0 238841

150 ORCHARD ROAD, ORCHARD PLAZA 08-02, SINGAPORE, U0 238841

Phone Numbers

(512) 774-8930
1 (646) 650-1351
202-618-1750
212-618-1750

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$58,007,812.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2025-05-20 
$22,650,000.00 
$22,650,000.00 
$0.00 
Debt 
13
2024-03-12 
$100,000.00 
$100,000.00 
$0.00 
Equity 
12
2018-08-10 
$24,000,000.00 
$24,000,000.00 
$0.00 
Equity 
11
2014-11-17 
$721,849.00 
$721,849.00 
$0.00 
Equity 
10
2014-10-09 
$229,393.00 
$229,393.00 
$0.00 
Equity 
9
2014-09-26 
$750,000.00 
$750,000.00 
$0.00 
Equity 
8
2014-09-24 
$1,189,749.00 
$1,189,749.00 
$0.00 
Equity 
7
2014-02-26 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
6
2013-11-25 
$934,923.00 
$1,000,000.00 
$65,077.00 
Equity 
5
2013-06-10 
$595,000.00 
$1,500,000.00 
$905,000.00 
Equity 
4
2013-05-01 
$416,000.00 
$500,000.00 
$84,000.00 
Equity 
3
2013-03-25 
$489,583.00 
$500,000.00 
$10,417.00 
Equity 
2
2012-04-24 
$1,204,152.00 
$3,000,000.00 
$1,795,848.00 
Equity 
1
2011-10-06 
$1,727,163.00 
$1,727,163.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN 
JOHN 
ALEXANDER 
DIRECTOR
PHILLIP 
 
BARNES 
DIRECTOR
LOUISE 
 
BATCHELOR 
EXECUTIVE OFFICER
SALVATORE 
THOMAS 
BUTERA 
EXECUTIVE OFFICER
ALAN 
 
COLMAN 
DIRECTOR
MARTIN 
 
FAULKES 
DIRECTOR
MARTIN 
CHARLES 
FAULKES 
EXECUTIVE OFFICER, DIRECTOR
GAEL 
 
FORTERRE 
EXECUTIVE OFFICER
EDWARD 
 
FUTCHER 
DIRECTOR
MICKIE 
 
HENSHALL 
DIRECTOR
TERIG 
 
HUGHES 
EXECUTIVE OFFICER
GUY 
 
INNES 
DIRECTOR
GUY 
ARCHIBALD 
INNES 
DIRECTOR
GUY 
ARCHIBOLD 
INNES 
DIRECTOR
JASMINE 
 
KWAY 
EXECUTIVE OFFICER
MALCOLM 
 
LEWIN 
EXECUTIVE OFFICER
JACOB 
 
MICALLEF 
EXECUTIVE OFFICER
GAETAN 
 
MICHEL 
EXECUTIVE OFFICER
MIKE 
 
O-CONNELL 
EXECUTIVE OFFICER
NICHOLAS 
 
PLUMMER 
EXECUTIVE OFFICER
ANDREW 
 
RETTER 
EXECUTIVE OFFICER
CAMERON 
 
REYNOLDS 
EXECUTIVE OFFICER, DIRECTOR
RODNEY 
 
ROOTSAERT 
EXECUTIVE OFFICER
RODNEY 
GERARD 
ROOTSAERT 
EXECUTIVE OFFICER
ETHEL 
 
RUBIN 
DIRECTOR
HABIB 
 
SKAFF 
DIRECTOR
TIMOTHY 
STILL 
DIRECTOR
JASON 
 
TERRELL 
EXECUTIVE OFFICER
SATU 
 
VAINIKKA 
DIRECTOR
DAVID 
CECIL 
VANSTON 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2025-05-20 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
 
2025-05-20 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2024-03-12 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2018-08-10 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-11-17 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-09-26 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-10-09 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-09-24 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2014-02-26 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Equity 
2013-11-25 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Equity 
2013-06-10 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Equity 
2013-05-01 
D
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Equity 
2013-03-25 
D
BIOTECHNOLOGY 
MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400] 
$1 - $1,000,000 
Equity 
2012-04-24 
D
BIOTECHNOLOGY 
MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400] 
NO REVENUES 
Equity 
2011-10-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GVC CAPITAL LLC
NONE
NONE
GVC CAPITAL LLC
NONE
NONE
FOUNDING ASSET MANAGEMENT ("FAM")
NONE
NONE
LAKE STREET CAPITAL MARKETS
NONE
NONE
FOUNDING ASSET MANAGEMENT
NONE
NONE
MZ ADVISORY PTE LTD
NONE
NONE
NONE
ANDREWS SECURITIES LLC
NONE
NONE
N/A
NONE